SeptiCyte® RAPID, an in vitro diagnostic test intended to aid differentiating infection-positive (sepsis) from infection-negative systemic inflammation in patients suspected of sepsis,...

Amytrx Therapeutics, an emerging pharmaceutical company specializing in innovative anti-inflammatory therapies, has announced that their abstract from the Revolutionizing Atopic Dermatitis (RAD)...

Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader in sustainability and electrification solutions, today announced that the Company is scheduled to participate in...

Axon (Nasdaq: AXON), the global public safety technology leader, today announced that it will report second quarter 2023 financial results after the market closes on Tuesday, August 8, 2023. Axon...

Anterix (NASDAQ: ATEX) today announced it will release its first quarter financial results for the 2024 fiscal year before the open of the market on Wednesday, August 2, 2023. Anterix senior...